May 25, 2013 3:16 AM ET

Pharmaceuticals

Company Overview of itherX Pharmaceuticals, Inc.

Company Overview

itherX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery and development of antiviral products for treatment of hepatitis C. Its products include ITX5061, a therapy targeted at inhibiting the entry of the hepatitis C virus (HCV) into liver cells; viral envelope target program to develop small molecule inhibitors of viral entry that targets the HCV envelope proteins; and host cell receptor target program, which engenders small molecule compounds that target a liver cell membrane protein. itherX Pharmaceuticals Inc. was formerly known as Immusol, Inc. and changed its name to itherX Pharmaceuticals Inc. in December 2007. The company was founded in 1992 and is based in ...

Detailed Description

10790 Roselle Street

San Diego, CA 92121

United States

Founded in 1992

Phone:

858-824-1100

Fax:

858-824-1112

www.itherx.com

Key Executives for itherX Pharmaceuticals, Inc.

Chief Executive Officer
Age: 70
Co-founder
Co-Founder and Director
Vice President
Age: 44
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Lupin Pharmaceuticals, Inc. United States
Sunovion Pharmaceuticals Inc. United States
Ives Formulation Company, Inc. United States
H. Bana Ltd. United States
NeuroTrack Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date		 Target
No transactions available in the past 12 months.
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact itherX Pharmaceuticals, Inc., please visit www.itherx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close